I am updating my blog page early because of an important event next week.
Next week on the 5th and 6th December there is a workshop at the European Medicines Agency looking at measuring the impact of pharmacovigilance activities in the EU. This workshop is referenced on my News section, but is so important that I am mentioning it here also. The workshop will be live streamed so visit EMA PV workshop for more details, and to join this important meeting.
I have kept below some of the information on the DSRU meeting in Prague, for those who were on Thanksgiving holiday and didn’t read it. It was a stimulating meeting:
The conference has been stimulating as we have discussed the principles of risk minimisation and the issues we face in all companies as we seek to minimise risks and the burden of any measures on patients and healthcare systems. There is clearly still much to be developed on this, but the thorny issue of what is effective risk minimisation remains elusive. My specific topics have been “Does One size fit all? Divergence of risk minimisation requirements amongst the 28 Member States” and “Risk Minimisation case studies and global considerations”.
As those who know me know, I am passionate about risk minimisation and the need to maximise benefit and minimise risk but also the need to balance the negative impact of such measures on healthcare systems and patients against their benefits in minimising risks.
Prague is a beautiful city and early morning/late evening walks have been great opportunities to see the city (and shop!). Whilst a little early for the Christmas markets, I did find one and managed to buy another glass globe for my collection.